Review





Similar Products

86
Jackson Laboratory m83 transgenic mouse jax004479
Specific α-syn antibody and probe P1 labeling of entire GI tract (esophagus, stomach, duodenum, jejunum, ileum, and colon) in transgenic mice <t>(JAX004479).</t> (a) Aggregated α-syn is observed in the mucosa layers and stained by both pS129 α-syn antibody and P1 (annotated with white arrows). Tissue layers are indicated by black arrows: muscularis externa (ME), submucosa (SM), and mucosa (M). Nuclei are in blue, α-syn in green, pS129 α-syn in orange, and probe in red. Scale bar represents 200 μm; (b) Total expression areas of α-syn aggregates labeled by pS129 α-syn antibody and P1 were quantified, with the highest expressions observed in the esophagus and colon; (c) High degree of colocalization (average of 0.91) was observed between pS129 α-syn antibody and probe P1 channels across all the GI tract tissues, determined by the Costes method. Manders colocalization and correlation coefficients are shown in Figure S7a ; (d) Probe positive predictive values were consistent across the respective GI tract tissues. Values on graphs are given as the mean ± SEM ( n = 3 per group); (e) P1 labeling is observed in the enteric neurons in colon tissue, marked by neuronal marker TUBB3 (green).
M83 Transgenic Mouse Jax004479, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/m83++/pmc13003444-248-12-8?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
m83 transgenic mouse jax004479 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Jackson Laboratory m83 transgenic mouse jax00447941
Specific α-syn antibody and probe P1 labeling of entire GI tract (esophagus, stomach, duodenum, jejunum, ileum, and colon) in transgenic mice <t>(JAX004479).</t> (a) Aggregated α-syn is observed in the mucosa layers and stained by both pS129 α-syn antibody and P1 (annotated with white arrows). Tissue layers are indicated by black arrows: muscularis externa (ME), submucosa (SM), and mucosa (M). Nuclei are in blue, α-syn in green, pS129 α-syn in orange, and probe in red. Scale bar represents 200 μm; (b) Total expression areas of α-syn aggregates labeled by pS129 α-syn antibody and P1 were quantified, with the highest expressions observed in the esophagus and colon; (c) High degree of colocalization (average of 0.91) was observed between pS129 α-syn antibody and probe P1 channels across all the GI tract tissues, determined by the Costes method. Manders colocalization and correlation coefficients are shown in Figure S7a ; (d) Probe positive predictive values were consistent across the respective GI tract tissues. Values on graphs are given as the mean ± SEM ( n = 3 per group); (e) P1 labeling is observed in the enteric neurons in colon tissue, marked by neuronal marker TUBB3 (green).
M83 Transgenic Mouse Jax00447941, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/m83++/pm41771532-241-12-8?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
m83 transgenic mouse jax00447941 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Jackson Laboratory homozygous m83
Specific α-syn antibody and probe P1 labeling of entire GI tract (esophagus, stomach, duodenum, jejunum, ileum, and colon) in transgenic mice <t>(JAX004479).</t> (a) Aggregated α-syn is observed in the mucosa layers and stained by both pS129 α-syn antibody and P1 (annotated with white arrows). Tissue layers are indicated by black arrows: muscularis externa (ME), submucosa (SM), and mucosa (M). Nuclei are in blue, α-syn in green, pS129 α-syn in orange, and probe in red. Scale bar represents 200 μm; (b) Total expression areas of α-syn aggregates labeled by pS129 α-syn antibody and P1 were quantified, with the highest expressions observed in the esophagus and colon; (c) High degree of colocalization (average of 0.91) was observed between pS129 α-syn antibody and probe P1 channels across all the GI tract tissues, determined by the Costes method. Manders colocalization and correlation coefficients are shown in Figure S7a ; (d) Probe positive predictive values were consistent across the respective GI tract tissues. Values on graphs are given as the mean ± SEM ( n = 3 per group); (e) P1 labeling is observed in the enteric neurons in colon tissue, marked by neuronal marker TUBB3 (green).
Homozygous M83, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/m83++/pm41763203-255-0-40?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
homozygous m83 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Jackson Laboratory m83
Specific α-syn antibody and probe P1 labeling of entire GI tract (esophagus, stomach, duodenum, jejunum, ileum, and colon) in transgenic mice <t>(JAX004479).</t> (a) Aggregated α-syn is observed in the mucosa layers and stained by both pS129 α-syn antibody and P1 (annotated with white arrows). Tissue layers are indicated by black arrows: muscularis externa (ME), submucosa (SM), and mucosa (M). Nuclei are in blue, α-syn in green, pS129 α-syn in orange, and probe in red. Scale bar represents 200 μm; (b) Total expression areas of α-syn aggregates labeled by pS129 α-syn antibody and P1 were quantified, with the highest expressions observed in the esophagus and colon; (c) High degree of colocalization (average of 0.91) was observed between pS129 α-syn antibody and probe P1 channels across all the GI tract tissues, determined by the Costes method. Manders colocalization and correlation coefficients are shown in Figure S7a ; (d) Probe positive predictive values were consistent across the respective GI tract tissues. Values on graphs are given as the mean ± SEM ( n = 3 per group); (e) P1 labeling is observed in the enteric neurons in colon tissue, marked by neuronal marker TUBB3 (green).
M83, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/m83++/pm41763203-257-1-13?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
m83 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Lenovo Inc lenovo thinkcentre m83 pc
Specific α-syn antibody and probe P1 labeling of entire GI tract (esophagus, stomach, duodenum, jejunum, ileum, and colon) in transgenic mice <t>(JAX004479).</t> (a) Aggregated α-syn is observed in the mucosa layers and stained by both pS129 α-syn antibody and P1 (annotated with white arrows). Tissue layers are indicated by black arrows: muscularis externa (ME), submucosa (SM), and mucosa (M). Nuclei are in blue, α-syn in green, pS129 α-syn in orange, and probe in red. Scale bar represents 200 μm; (b) Total expression areas of α-syn aggregates labeled by pS129 α-syn antibody and P1 were quantified, with the highest expressions observed in the esophagus and colon; (c) High degree of colocalization (average of 0.91) was observed between pS129 α-syn antibody and probe P1 channels across all the GI tract tissues, determined by the Costes method. Manders colocalization and correlation coefficients are shown in Figure S7a ; (d) Probe positive predictive values were consistent across the respective GI tract tissues. Values on graphs are given as the mean ± SEM ( n = 3 per group); (e) P1 labeling is observed in the enteric neurons in colon tissue, marked by neuronal marker TUBB3 (green).
Lenovo Thinkcentre M83 Pc, supplied by Lenovo Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/m83++/pmc12851487-65-5-5?v=Lenovo+Inc
Average 86 stars, based on 1 article reviews
lenovo thinkcentre m83 pc - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Jackson Laboratory m83 hemizygous mice
A <t>M83</t> mice underwent stereotaxic surgery for inoculation of aSyn PFF-1, aSyn PFF-2 or PBS control into the right dorsal striatum. At 8 weeks post injection, they subsequently underwent a motor test battery, including assessments of motor strength, motor coordination and gait. Following completion, they were assessed for the cognitive ability to acquire stimulus-response associations, with the ‘Visuomotor Conditional Learning’ at 9-12 weeks post injection. At 16 weeks post-injection, they repeated the motor test battery, and then were processed for pathology and biochemistry. B Brain homogenates from aSyn PFF-1 and PFF-2 inoculated mice both displayed resistance to proteinase K but exhibited variable banding patterns upon digestion, as assessed by Western Blot using an antibody for total aSyn. C, D Furthermore, the same brain homogenates were evaluated by dotblots using an antibody with high affinity for aggregated aSyn (chBIIB054), revealing that while both fibril types exhibited significant binding, aSyn PFF-2 brain homogenates presented with a stronger signal (Welch’s ANOVA test, W 2, 5.34 = 7.03, p < 0.05, in which Welch-corrected unpaired t-tests revealed to be driven by a significant difference between PBS control and PFF-2 (p < 0.05). Graphics made with Biorender.com.
M83 Hemizygous Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/m83++/pmc12804908-49-0-12?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
m83 hemizygous mice - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Jackson Laboratory hemizygous m83 transgenic mice m83
A <t>M83</t> mice underwent stereotaxic surgery for inoculation of aSyn PFF-1, aSyn PFF-2 or PBS control into the right dorsal striatum. At 8 weeks post injection, they subsequently underwent a motor test battery, including assessments of motor strength, motor coordination and gait. Following completion, they were assessed for the cognitive ability to acquire stimulus-response associations, with the ‘Visuomotor Conditional Learning’ at 9-12 weeks post injection. At 16 weeks post-injection, they repeated the motor test battery, and then were processed for pathology and biochemistry. B Brain homogenates from aSyn PFF-1 and PFF-2 inoculated mice both displayed resistance to proteinase K but exhibited variable banding patterns upon digestion, as assessed by Western Blot using an antibody for total aSyn. C, D Furthermore, the same brain homogenates were evaluated by dotblots using an antibody with high affinity for aggregated aSyn (chBIIB054), revealing that while both fibril types exhibited significant binding, aSyn PFF-2 brain homogenates presented with a stronger signal (Welch’s ANOVA test, W 2, 5.34 = 7.03, p < 0.05, in which Welch-corrected unpaired t-tests revealed to be driven by a significant difference between PBS control and PFF-2 (p < 0.05). Graphics made with Biorender.com.
Hemizygous M83 Transgenic Mice M83, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/m83++/pm41372188-237-0-8?v=Jackson+Laboratory
Average 86 stars, based on 1 article reviews
hemizygous m83 transgenic mice m83 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

Image Search Results


Specific α-syn antibody and probe P1 labeling of entire GI tract (esophagus, stomach, duodenum, jejunum, ileum, and colon) in transgenic mice (JAX004479). (a) Aggregated α-syn is observed in the mucosa layers and stained by both pS129 α-syn antibody and P1 (annotated with white arrows). Tissue layers are indicated by black arrows: muscularis externa (ME), submucosa (SM), and mucosa (M). Nuclei are in blue, α-syn in green, pS129 α-syn in orange, and probe in red. Scale bar represents 200 μm; (b) Total expression areas of α-syn aggregates labeled by pS129 α-syn antibody and P1 were quantified, with the highest expressions observed in the esophagus and colon; (c) High degree of colocalization (average of 0.91) was observed between pS129 α-syn antibody and probe P1 channels across all the GI tract tissues, determined by the Costes method. Manders colocalization and correlation coefficients are shown in Figure S7a ; (d) Probe positive predictive values were consistent across the respective GI tract tissues. Values on graphs are given as the mean ± SEM ( n = 3 per group); (e) P1 labeling is observed in the enteric neurons in colon tissue, marked by neuronal marker TUBB3 (green).

Journal: ACS Chemical Neuroscience

Article Title: Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe

doi: 10.1021/acschemneuro.6c00069

Figure Lengend Snippet: Specific α-syn antibody and probe P1 labeling of entire GI tract (esophagus, stomach, duodenum, jejunum, ileum, and colon) in transgenic mice (JAX004479). (a) Aggregated α-syn is observed in the mucosa layers and stained by both pS129 α-syn antibody and P1 (annotated with white arrows). Tissue layers are indicated by black arrows: muscularis externa (ME), submucosa (SM), and mucosa (M). Nuclei are in blue, α-syn in green, pS129 α-syn in orange, and probe in red. Scale bar represents 200 μm; (b) Total expression areas of α-syn aggregates labeled by pS129 α-syn antibody and P1 were quantified, with the highest expressions observed in the esophagus and colon; (c) High degree of colocalization (average of 0.91) was observed between pS129 α-syn antibody and probe P1 channels across all the GI tract tissues, determined by the Costes method. Manders colocalization and correlation coefficients are shown in Figure S7a ; (d) Probe positive predictive values were consistent across the respective GI tract tissues. Values on graphs are given as the mean ± SEM ( n = 3 per group); (e) P1 labeling is observed in the enteric neurons in colon tissue, marked by neuronal marker TUBB3 (green).

Article Snippet: Two strains of transgenic mice were imported from the Jackson Laboratory: (i) M83 transgenic mouse JAX004479 and (ii) double transgenic mouse JAX010799.

Techniques: Labeling, Transgenic Assay, Staining, Expressing, Marker

A M83 mice underwent stereotaxic surgery for inoculation of aSyn PFF-1, aSyn PFF-2 or PBS control into the right dorsal striatum. At 8 weeks post injection, they subsequently underwent a motor test battery, including assessments of motor strength, motor coordination and gait. Following completion, they were assessed for the cognitive ability to acquire stimulus-response associations, with the ‘Visuomotor Conditional Learning’ at 9-12 weeks post injection. At 16 weeks post-injection, they repeated the motor test battery, and then were processed for pathology and biochemistry. B Brain homogenates from aSyn PFF-1 and PFF-2 inoculated mice both displayed resistance to proteinase K but exhibited variable banding patterns upon digestion, as assessed by Western Blot using an antibody for total aSyn. C, D Furthermore, the same brain homogenates were evaluated by dotblots using an antibody with high affinity for aggregated aSyn (chBIIB054), revealing that while both fibril types exhibited significant binding, aSyn PFF-2 brain homogenates presented with a stronger signal (Welch’s ANOVA test, W 2, 5.34 = 7.03, p < 0.05, in which Welch-corrected unpaired t-tests revealed to be driven by a significant difference between PBS control and PFF-2 (p < 0.05). Graphics made with Biorender.com.

Journal: Translational Psychiatry

Article Title: Impairment in stimulus-response learning as a cognitive biomarker in a model of synucleinopathy

doi: 10.1038/s41398-025-03795-5

Figure Lengend Snippet: A M83 mice underwent stereotaxic surgery for inoculation of aSyn PFF-1, aSyn PFF-2 or PBS control into the right dorsal striatum. At 8 weeks post injection, they subsequently underwent a motor test battery, including assessments of motor strength, motor coordination and gait. Following completion, they were assessed for the cognitive ability to acquire stimulus-response associations, with the ‘Visuomotor Conditional Learning’ at 9-12 weeks post injection. At 16 weeks post-injection, they repeated the motor test battery, and then were processed for pathology and biochemistry. B Brain homogenates from aSyn PFF-1 and PFF-2 inoculated mice both displayed resistance to proteinase K but exhibited variable banding patterns upon digestion, as assessed by Western Blot using an antibody for total aSyn. C, D Furthermore, the same brain homogenates were evaluated by dotblots using an antibody with high affinity for aggregated aSyn (chBIIB054), revealing that while both fibril types exhibited significant binding, aSyn PFF-2 brain homogenates presented with a stronger signal (Welch’s ANOVA test, W 2, 5.34 = 7.03, p < 0.05, in which Welch-corrected unpaired t-tests revealed to be driven by a significant difference between PBS control and PFF-2 (p < 0.05). Graphics made with Biorender.com.

Article Snippet: M83 hemizygous mice (M83 + /− mice; B6; C3H-Tg[SNCA]83Vle/J) were obtained from Jackson Laboratory (004479) and maintained in-house on a C57BL/C3H background.

Techniques: Control, Injection, Battery, Western Blot, Binding Assay

A Schematic of Visuomotor Conditional Learning (VMCL) task. Cognitive assessments were conducted within touchscreen systems equipped with a touch-sensitive screen, a reward magazine attached to a reward pump for delivery of strawberry milkshake liquid reward and ABET cognition software ( above ). VMCL was employed to evaluate the acquisition of stimulus-response (S-R) contingencies, with subjects learning the conditional rule: “if visual stimulus A is presented, make motor response to the right-flanking window; if visual stimulus B is presented, make motor response to the flight-flanking window” ( below ). All subjects underwent VMCL testing for 20 sessions, 5-7 sessions per week. B M83 mice inoculated with aSyn PFF-1 and PFF-2 were significantly impaired at acquiring VMCL, as demonstrated by lower percent correct responses relative to PBS-inoculated mice (2-way RM ANOVA, Group x Session: main effect of group (F 2,60=10.53 , p < 0.001), main effect of session (F 2.686, 161.2=10.53 , p < 0.0001) and significant interaction (F 8,240=3.131 , p < 0.01), in which Šídák’s multiple comparisons revealed to be driven by a significant difference between PBS control and PFF-1 in sessions 2 (adj. p < 0.05), 4 (adj. p < 0.05) and 5 (adj. p < 0.05), and a significant difference between PBS control and PFF-2 in sessions 2 (adj. p < 0.01), 3 (adj. p < 0.001), 4 (adj. p < 0.01), and 5 (adj. p < 0.01)). C While all groups began at chance in Block 1 (1-way ANOVA, p > 0.05), (D) both aSyn-inoculated groups were significantly impaired relative to controls in Block 5 (1-way ANOVA, F 8.764 , p < 0.001, in which Šídák’s multiple comparisons revealed to be driven by a significant difference between PBS controls and PFF-1 (adj. p < 0.05), and between PBS controls PFF-2 (adj. p < 0.001)). E No significant difference was found in the percentage of missed trials across groups (RM Mixed-Effects Model, Group x Session: main effect of session (F 2.050,118.4= 20.55 , p < 0.0001), but no main effect of group or interaction (p > 0.05)), (F) but aSyn PFF-1 and PFF-2 mice exhibited a greater number of correction trials (2-way RM ANOVA, Group x Session: main effect of group (F 2,60= 6.008 , p < 0.01), main effect of session (F 3.240,194.4= 66.22 , p < 0.0001) but no interaction (p > 0.05)), and (G) an elevated perseveration index compared to controls (RM Mixed-Effects Model, Group x Session: main effect of group (F 2,60=4.648 , p < 0.05), main effect of session (F 3.191,171.5=24.48 , p < 0.0001), but no interaction (p > 0.05)). Furthermore, comparing task latencies, no significant difference was found in the latency to make correct choices (H) (2-way RM ANOVA: Group x Session: p > 0.05), but aSyn PFF-1 and PFF-2 mice took significantly longer to make incorrect choices (I) across VMCL acquisition compared to PBS controls (2-way RM ANOVA: Group x Session: main effect of group (F 2,60=5.384 , p < 0.01), main effect of session (F 3.202,192.1= 62.37 , p < 0.0001), and significant interaction (F 8,240=1.985 , p < 0.05), in which Šídák’s multiple comparisons revealed to be driven by a significant difference between PBS control and PFF-1 in sessions 2 (adj. p < 0.01), 3 (adj. p < 0.01) and 5 (adj. p < 0.05), and a significant difference between PBS control and PFF-2 in sessions 3 (adj. p < 0.05) and 5 (adj. p < 0.05)). No significant difference was found for the latency to collect rewards (J) (2-way RM ANOVA, Group x Session: main effect of session (F 2.275,135.9=17.67 , p < 0.0001), but no main effect of group or interaction (p > 0.05)). Data presented as Mean + SEM, * p < 0.05, ** p < 0.01, *** p < 0.001. Graphics made with Biorender.com.

Journal: Translational Psychiatry

Article Title: Impairment in stimulus-response learning as a cognitive biomarker in a model of synucleinopathy

doi: 10.1038/s41398-025-03795-5

Figure Lengend Snippet: A Schematic of Visuomotor Conditional Learning (VMCL) task. Cognitive assessments were conducted within touchscreen systems equipped with a touch-sensitive screen, a reward magazine attached to a reward pump for delivery of strawberry milkshake liquid reward and ABET cognition software ( above ). VMCL was employed to evaluate the acquisition of stimulus-response (S-R) contingencies, with subjects learning the conditional rule: “if visual stimulus A is presented, make motor response to the right-flanking window; if visual stimulus B is presented, make motor response to the flight-flanking window” ( below ). All subjects underwent VMCL testing for 20 sessions, 5-7 sessions per week. B M83 mice inoculated with aSyn PFF-1 and PFF-2 were significantly impaired at acquiring VMCL, as demonstrated by lower percent correct responses relative to PBS-inoculated mice (2-way RM ANOVA, Group x Session: main effect of group (F 2,60=10.53 , p < 0.001), main effect of session (F 2.686, 161.2=10.53 , p < 0.0001) and significant interaction (F 8,240=3.131 , p < 0.01), in which Šídák’s multiple comparisons revealed to be driven by a significant difference between PBS control and PFF-1 in sessions 2 (adj. p < 0.05), 4 (adj. p < 0.05) and 5 (adj. p < 0.05), and a significant difference between PBS control and PFF-2 in sessions 2 (adj. p < 0.01), 3 (adj. p < 0.001), 4 (adj. p < 0.01), and 5 (adj. p < 0.01)). C While all groups began at chance in Block 1 (1-way ANOVA, p > 0.05), (D) both aSyn-inoculated groups were significantly impaired relative to controls in Block 5 (1-way ANOVA, F 8.764 , p < 0.001, in which Šídák’s multiple comparisons revealed to be driven by a significant difference between PBS controls and PFF-1 (adj. p < 0.05), and between PBS controls PFF-2 (adj. p < 0.001)). E No significant difference was found in the percentage of missed trials across groups (RM Mixed-Effects Model, Group x Session: main effect of session (F 2.050,118.4= 20.55 , p < 0.0001), but no main effect of group or interaction (p > 0.05)), (F) but aSyn PFF-1 and PFF-2 mice exhibited a greater number of correction trials (2-way RM ANOVA, Group x Session: main effect of group (F 2,60= 6.008 , p < 0.01), main effect of session (F 3.240,194.4= 66.22 , p < 0.0001) but no interaction (p > 0.05)), and (G) an elevated perseveration index compared to controls (RM Mixed-Effects Model, Group x Session: main effect of group (F 2,60=4.648 , p < 0.05), main effect of session (F 3.191,171.5=24.48 , p < 0.0001), but no interaction (p > 0.05)). Furthermore, comparing task latencies, no significant difference was found in the latency to make correct choices (H) (2-way RM ANOVA: Group x Session: p > 0.05), but aSyn PFF-1 and PFF-2 mice took significantly longer to make incorrect choices (I) across VMCL acquisition compared to PBS controls (2-way RM ANOVA: Group x Session: main effect of group (F 2,60=5.384 , p < 0.01), main effect of session (F 3.202,192.1= 62.37 , p < 0.0001), and significant interaction (F 8,240=1.985 , p < 0.05), in which Šídák’s multiple comparisons revealed to be driven by a significant difference between PBS control and PFF-1 in sessions 2 (adj. p < 0.01), 3 (adj. p < 0.01) and 5 (adj. p < 0.05), and a significant difference between PBS control and PFF-2 in sessions 3 (adj. p < 0.05) and 5 (adj. p < 0.05)). No significant difference was found for the latency to collect rewards (J) (2-way RM ANOVA, Group x Session: main effect of session (F 2.275,135.9=17.67 , p < 0.0001), but no main effect of group or interaction (p > 0.05)). Data presented as Mean + SEM, * p < 0.05, ** p < 0.01, *** p < 0.001. Graphics made with Biorender.com.

Article Snippet: M83 hemizygous mice (M83 + /− mice; B6; C3H-Tg[SNCA]83Vle/J) were obtained from Jackson Laboratory (004479) and maintained in-house on a C57BL/C3H background.

Techniques: Software, Control, Blocking Assay